Akebia Ther (AKBA) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $1.32
• Market Cap: $321.09M
• EPS: $-0.08
• 52-Week High: $4.08
• 52-Week Low: $1.14

Market Sentiment

Akebia Ther currently has a Neutral sentiment score of 0.13.

About Akebia Ther

Akebia Therapeutics, Inc. (AKBA), based in Cambridge, Massachusetts, is a biopharmaceutical leader focused on developing and commercializing innovative therapies for chronic kidney disease. The company has a strong pipeline that targets significant unmet medical needs in renal care, leveraging advanced research and strategic partnerships to deliver effective treatment solutions. With its commitment to improving patient outcomes, Akebia is well-positioned to make a substantial impact in the ev...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Akebia Ther and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does AKBA pay dividends?

Akebia Ther (AKBA) does not currently pay a regular dividend.

What is AKBA's market cap?

Akebia Ther (AKBA) has a market capitalization of $321.09M with a current stock price of $1.32.